Corticosteroids’ safety affirmed in treatment of childhood asthma

Children being treated with a short course of oral corticosteroids for an acute asthma attack may experience a brief and transient depression of their immune response, according to a recent study conducted by Université de Montréal.

Patient expectations can affect drug efficacy

A new study published in Science Translational Medicine found that patients? expectations regarding the effects of pain medications influence medication efficacy as well as the pain-related brain pathways activated during treatment.

U.S. Marshals seize Auralgan otic solution

U.S. Marshals acting on a request of FDA seized all lots of Auralgan otic solution from Integrated Commercialization Solutions in Brooks, Ky.

Tifacogin ineffective against severe community-acquired pneumonia

Tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a global study published online in the American Thoracic Society?s American Journal of Respiratory and Critical Care Medicine, ahead of the print edition.

Steroids increase bowel perforation risk for RA

Rheumatoid arthritis patients who have been treated with glucocorticoids have an increased risk of gastrointestinal perforation, according to a study published in Arthritis & Rheumatism.

Company expands generic warfarin recall to other product lines

A recent recall of generic warfarin tablets was expanded to include 6 other drug products prepared on the same packaging line.

Clinical Trials Update: March 4, 2011 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Pfizer arthritis drug meets main goals of trial (Reuters)

Reuters - Pfizer Inc said on Friday that its experimental rheumatoid arthritis drug met the main goals of a late-stage clinical trial, a welcome boost for the world's largest drugmaker as it seeks new products to offset those that are losing patent protection.

FDA says migraine drug ups risk for birth defects (Reuters)

Reuters - A headache medication for migraines increases the risk for birth defects in babies born to pregnant mothers taking the medication, U.S. health officials said on Friday.

Clinical Trials Update: March 3, 2011 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Next Page »